Repeated inspiratory occlusions in anesthetized rats acutely increase blood coagulability as assessed by thromboelastography

Respiratory Physiology and Neurobiology

Volumn 171, Issue 1, 2010, Pages 61-66

  Othman, M ^a   Gordon, S P ^a   Iscoe, S ^a  

^a QUEEN S UNIVERSITY   (Canada)

Author keywords

Blood; Coagulation; Hemostasis; Obstructive sleep apnea

Indexed keywords

AIRWAY OBSTRUCTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERIAL PRESSURE; ARTICLE; BLOOD CLOTTING; BLOOD CLOTTING TIME; BLOOD PRESSURE; BREATHING; CONTROLLED STUDY; FIBRIN FORMATION; HEMOSTASIS; HYPERCOAGULABILITY; NONHUMAN; PRIORITY JOURNAL; RAT; SLEEP APNEA SYNDROME; THROMBOELASTOGRAPHY; TRACHEA PRESSURE;

ADJUVANTS, ANESTHESIA; ANESTHESIA; ANIMALS; BLOOD COAGULATION; CONTINUOUS POSITIVE AIRWAY PRESSURE; DISEASE MODELS, ANIMAL; PENTOBARBITAL; RATS; RATS, SPRAGUE-DAWLEY; RESPIRATORY INSUFFICIENCY; SLEEP APNEA, OBSTRUCTIVE; THROMBELASTOGRAPHY;

EID: 77949567630     PISSN: 15699048     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.resp.2010.01.010     Document Type: Article

References (64)

1. Akinnusi M.E., Paasch L.L., Szarpa K.R., Wallace P.K., and El Solh A.A. Impact of nasal continuous positive airway pressure therapy on markers of platelet activation in patients with obstructive sleep apnea. Respiration 77 (2009) 25-31
2. Al Lawati N.M., Patel S.R., and Ayas N.T. Epidemiology, risk factors, and consequences of obstructive sleep apnea and short sleep duration. Prog. Cardiovasc. Dis. 51 (2009) 285-293
3. Alessi M.C., and Juhan-Vague I. Metabolic syndrome, haemostasis and thrombosis. Thromb. Haemost. 99 (2008) 995-1000
4. Atkeson A., Yeh S.Y., Malhotra A., and Jelic S. Endothelial function in obstructive sleep apnea. Prog. Cardiovasc. Dis. 51 (2009) 351-362
5. Ayers L., Ferry B., Craig S., Nicoll D., Stradling J.R., and Kohler M. Circulating cell-derived microparticles in patients with minimally symptomatic obstructive sleep apnoea. Eur. Respir. J. 33 (2009) 574-580
6. Biro G., Hatcher J.D., and Jennings D.B. The role of the aortic body chemoreceptors in the cardiac and respiratory responses to acute hypoxia in the anesthetized dog. Can. J. Physiol. Pharmacol. 51 (1973) 249-259
7. Bokinsky G., Miller M., Ault K., Husband P., and Mitchell J. Spontaneous platelet activation and aggregation during obstructive sleep apnea and its response to therapy with nasal continuous positive airway pressure. A preliminary investigation. Chest 108 (1995) 625-630
8. Brezinski D.A., Tofler G.H., Muller J.E., Pohjola-Sintonen S., Willich S.N., Schafer A.I., Czeisler C.A., and Williams G.H. Morning increase in platelet aggregability. Association with assumption of the upright posture. Circulation 78 (1988) 35-40
9. Brzecka A., and Davies S.F. Profound sleep hypoxia in morbidly obese hypercapnic patients with obstructive sleep apnea. Mater. Med. Pol. 25 (1993) 63-71
10. 50 conditions. Comp. Biochem. Physiol. 106A (1994) 775-782
11. Chin K., Ohi M., Kita H., Noguchi T., Otsuka N., Tsuboi T., Mishima M., and Kuno K. Effects of NCPAP therapy on fibrinogen levels in obstructive sleep apnea syndrome. Am. J. Respir. Crit. Care Med. 153 (1996) 1972-1976
12. Dematteis M., Godin-Ribuot D., Arnaud C., Ribuot C., Stanke-Labesque F., Pépin J.L., and Lévy P. Cardiovascular consequences of sleep-disordered breathing: contribution of animal models to understanding the human disease. ILAR J. 50 (2009) 262-281
13. Di Tullio M.R., Homma S., Jin Z., and Sacco R.L. Aortic atherosclerosis, hypercoagulability, and stroke: the APRIS (aortic plaque and risk of ischemic stroke) study. J. Am. Coll. Cardiol. 52 (2008) 855-861
14. Donahue S.M., and Otto C.M. Thromboelastography: a tool for measuring hypercoagulability, hypocoagulability, and fibrinolysis. J. Vet. Emerg. Med. Care 15 (2005) 9-16
15. Dunleavy M., Dooley M., Cox D., and Bradford A. Chronic intermittent asphyxia increases platelet reactivity in rats. Exp. Physiol. 90 (2005) 411-416
16. Eisensehr I., Ehrenberg B.L., Noachtar S., Korbett K., Byrne A., McAuley A., and Palabrica T. Platelet activation, epinephrine, and blood pressure in obstructive sleep apnea syndrome. Neurology 51 (1998) 188-195
17. El-Sayed M.S., El-Sayed Z., and Ahmazizad S. Exercise and training effects on blood haemostasis in health and disease. An update. Sports Med. 34 (2004) 181-200
18. El Solh A.A., Akinnusi M.E., Berim I.G., Peter A.M., Paasch L.L., and Szarpa K.R. Hemostatic implications of endothelial cell apoptosis in obstructive sleep apnea. Sleep Breath 12 (2008) 331-337
19. Farré R., Montserrat J.M., and Navajas D. Morbidity due to obstructive sleep apnea: insights from animal models. Curr. Opin. Pulm. Med. 14 (2008) 530-536
20. Frumento R.J., Hirsh A.L., Parides M.K., and Benett-Guerrero E. J. Cardiothor. Vasc. Anesth. 16 (2002) 551-554
21. Garvey J.F., Taylor C.T., and McNicholas W.T. Cardiovascular disease in obstructive sleep apnoea syndrome: the role of intermittent hypoxia and inflammation. Eur. Respir. J. 33 (2009) 1195-1205
22. Geiser T., Buck F., Meyer B.J., Bassetti C., Haeberli A., and Gugger M. In vivo platelet activation is increased during sleep in patients with obstructive sleep apnea syndrome. Respiration 69 (2002) 229-234
23. Guardiola J.J., Matheson P.J., Clavijo L.C., Wilson M.A., and Fletcher E.C. Hypercoagulability in patients with obstructive sleep apnea. Sleep Med. 2 (2001) 517-523
24. Hui D.S., Ko F.W., Fok J.P., Chan M.C., Li T.S., Tomlinson B., and Cheng G. The effects of nasal continuous positive airway pressure on platelet activation in obstructive sleep apnea syndrome. Chest 125 (2004) 1768-1775
25. Jean-Louis G., Zizi F., Clark L.T., Brown C.D., and McFarlane S.I. Obstructive sleep apnea and cardiovascular disease: role of the metabolic syndrome and its components. J. Clin. Sleep Med. 4 (2008) 261-272
26. Kakar P., and Lip G.Y. Hypertension: endothelial dysfunction, the prothrombotic state and antithrombotic therapy. Expert Rev. Cardiovasc. Ther. 5 (2007) 441-450
27. Kobayashi K., Nishimura Y., Shimada T., Yoshimura S., Funada Y., Satouchi M., and Yokoyama M. Effect of continuous positive airway pressure on soluble CD40 ligand in patients with obstructive sleep apnea syndrome. Chest 129 (2006) 632-637
28. Kohler M., Craig S., Nicoll D., Leeson P., Davies R.J., and Stradling J.R. Endothelial function and arterial stiffness in minimally symptomatic obstructive sleep apnea. Am. J. Respir. Crit. Care Med. 178 (2008) 984-988
29. Levi M., Nieuwdorp M., van der Poll T., and Stroes E. Metabolic modulation of inflammation-induced activation of coagulation. Semin. Thromb. Hemost. 34 (2008) 26-32
30. Lindberg E., and Gislason T. Epidemiology of sleep-related obstructive breathing. Sleep Med. Rev. 4 (2000) 411-433
31. Lippi G., and Maffulli N. Biological influence of physical exercise on hemostasis. Semin. Thromb. Hemost. 35 (2009) 269-276
32. Mackman N., Tilley R.E., and Key N.S. Role of the extrinsic pathway of blood coagulation in hemostasis and thrombosis. Arterioscler. Thromb. Vasc. Biol. 27 (2007) 1687-1693
33. McNicholas W.T., and Bonsignore M.R. Management Committee of EU COST ACTION B26. Sleep apnoea as an independent risk factor for cardiovascular disease: current evidence, basic mechanisms and research priorities. Eur. Respir. J. 29 (2007) 156-178
34. Nácher M., Farré R., Montserrat J.M., Torres M., Navajas D., Bulbena O., and Serrano-Mollar A. Biological consequences of oxygen desaturation and respiratory effort in an acute animal model of obstructive sleep apnea (OSA). Sleep Med. 10 (2009) 892-897
35. Nácher M., Serrano-Mollar A., Farré R., Panes J., Segui J., and Montserrat J.M. Recurrent obstructive apneas trigger early systemic inflammation in a rat model of sleep apnea. Respir. Physiol. Neurobiol. 155 (2007) 93-96
36. Nobili L., Schiavi G., Bozano E., De Carli F., Ferrillo F., and Nobili F. Morning increase of whole blood viscosity in obstructive sleep apnea syndrome. Clin. Hemorheol. Microcirc. 22 (2000) 21-27
37. Pack A.I., and Gislason T. Obstructive sleep apnea and cardiovascular disease: a perspective and future directions. Prog. Cardiovasc. Dis. 51 (2009) 434-451
38. Parati G., Lombardi C., and Narkiewicz K. Sleep apnea: epidemiology, pathophysiology, and relation to cardiovascular risk. Am. J. Physiol. 293 (2007) R1671-R1683
39. Paszkowiak J.J., and Dardik A. Arterial wall shear stress: observations from the bench to the bedside. Vasc. Endovascular. Surg. 37 (2003) 47-57
40. Peled N., Kassirer M., Kramer M.R., Rogowski O., Shlomi D., Fox B., Berliner A.S., and Shitrit D. Increased erythrocyte adhesiveness and aggregation in obstructive sleep apnea syndrome. Thromb. Res. 121 (2008) 631-636
41. Rångemark C., Hedner J.A., Carlson J.T., Gleerup G., and Winther K. Platelet function and fibrinolytic activity in hypertensive and normotensive sleep apnea patients. Sleep 18 (1995) 188-194
42. Robinson G.V., Pepperell J.C., Segal H.C., Davies R.J., and Stradling J.R. Circulating cardiovascular risk factors in obstructive sleep apnoea: data from randomised controlled trials. Thorax 59 (2004) 777-782
43. Sanner B.M., Konermann M., Tepel M., Groetz J., Mummenhoff C., and Zidek W. Platelet function in patients with obstructive sleep apnoea syndrome. Eur. Respir. J. 16 (2000) 648-652
44. Scarabin P.Y., Aillaud M.F., Amouyel P., Evans A., Luc G., Ferrières J., Arveiler D., and Juhan-Vague I. Associations of fibrinogen, factor VII and PAI-1 with baseline findings among 10,500 male participants in a prospective study of myocardial infarction-the PRIME Study. Prospective epidemiological study of myocardial infarction. Thromb. Haemost. 80 (1998) 749-756
45. Simpson J.A., Brunt K.R., and Iscoe S. Repeated inspiratory occlusions acutely impair myocardial function in rats. J. Physiol. 586 (2008) 2345-2355
46. Smith J.E. Effects of strenuous exercise on haemostasis. Br. J. Sports Med. 37 (2003) 433-435
47. Somers V.K., Dyken M.E., Clary M.P., and Abboud F.M. Sympathetic neural mechanisms in obstructive sleep apnea. J. Clin. Invest. 96 (1995) 1897-1904
48. Somers V.K., White D.P., Amin R., Abraham W.T., Costa F., Culebras A., Daniels S., Floras J.S., Hunt C.E., Olson L.J., Pickering T.G., Russell R., Woo M., and Young T. Sleep apnea and cardiovascular disease: an American Heart Association/American College of Cardiology Foundation Scientific Statement from the American Heart Association Council for High Blood Pressure Research Professional Education Committee, Council on Clinical Cardiology, Stroke Council, and Council on Cardiovascular Nursing. J. Am. Coll. Cardiol. 52 (2008) 686-717
49. Steiner S., Jax T., Evers S., Hennersdorf M., Schwalen A., and Strauer B.E. Altered blood rheology in obstructive sleep apnea as a mediator of cardiovascular risk. Cardiology 104 (2005) 92-96
50. Stoll G., Kleinschnitz C., and Nieswandt B. Molecular mechanisms of thrombus formation in ischemic stroke: novel insights and targets for treatment. Blood 112 (2008) 3555-3562
51. Strumza M.V., Hainaut J., and Strumza-Poutonnet J.M. Mécanisme déclenchant l'hypercoagulabilité sanguine dans l'hypoxie sévère. C. R. Seances Soc. Biol. Fil. 165 (1971) 1861-1863
52. 2 et du pH du sang arteriel sur les variations hypoxiques de la coagulabilité plasmatique. C. R. Seances Soc. Biol. Fil. 166 (1972) 787-790
53. Strumza M.V., Migne J., and Maupin B. Effets rapides de l'hypoxie sur certains facteurs de la coagulation sanguine et de la fibrinolyse. C. R. Seances Soc. Biol. Fil. 164 (1970) 962-966
54. Takagi T., Morser J., Gabazza E.C., Qin L., Fujiwara A., Naito M., Yamaguchi A., Kobayashi T., D'Alessandro-Gabazza C.N., Boveda Ruiz D., Gil Bernabe P., Iwasaki Y., Takei Y., and Taguchi O. The coagulation and protein C pathways in patients with sleep apnea. Lung 187 (2009) 209-213
55. Tazbirek M., Slowinska L., Skoczynski S., and Pierzchala W. Short-term continuous positive airway pressure therapy reverses the pathological influence of obstructive sleep apnea on blood rheology parameters. Clin. Hemorheol. Microcirc. 41 (2009) 241-249
56. Tilkian A.G., Guilleminault C., Schroeder J.S., Lehrman K.L., Simmons F.B., and Dement W.C. Hemodynamics in sleep-induced apnea. Studies during wakefulness and sleep. Ann. Intern. Med. 85 (1976) 714-719
57. Vine A.K. Recent advances in haemostasis and thrombosis. Retina 29 (2009) 1-7
58. von Känel R., and Dimsdale J.E. Effects of sympathetic activation by adrenergic infusions on hemostasis in vivo. Eur. J. Haematol. 65 (2000) 357-369
59. von Känel R., and Dimsdale J.E. Hemostatic alterations in patients with obstructive sleep apnea and the implications for cardiovascular disease. Chest 124 (2003) 1956-1967
60. von Känel R., Loredo J.S., Ancoli-Israel S., and Dimsdale J.E. Association between sleep apnea severity and blood coagulability: treatment effects of nasal continuous positive airway pressure. Sleep Breath. 10 (2006) 139-146
61. von Känel R., Loredo J.S., Ancoli-Israel S., Mills P.J., Natarajan L., and Dimsdale J.E. Association between polysomnographic measures of disrupted sleep and prothrombotic factors. Chest 131 (2007) 733-739
62. von Känel R., Loredo J.S., Powell F.L., Adler K.A., and Dimsdale J.E. Short-term isocapnic hypoxia and coagulation activation in patients with sleep apnea. Clin. Hemorheol. Microcirc. 33 (2005) 369-377
63. Zamarron C., Garcia Paz V., and Riveiro A. Obstructive sleep apnea syndrome is a systemic disease. Current evidence. Eur. J. Int. Med. 19 (2008) 390-398
64. Zamarron C., Ricoy J., Riveiro A., and Gude F. Plasminogen activator inhibitor-1 in obstructive sleep apnea patients with and without hypertension. Lung 186 (2008) 151-156